BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 21261306)

  • 1. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a multidisciplinary approach to solve complex nano EHS problems by the UC Center for the Environmental Implications of Nanotechnology.
    Xia T; Malasarn D; Lin S; Ji Z; Zhang H; Miller RJ; Keller AA; Nisbet RM; Harthorn BH; Godwin HA; Lenihan HS; Liu R; Gardea-Torresdey J; Cohen Y; Mädler L; Holden PA; Zink JI; Nel AE
    Small; 2013 May; 9(9-10):1428-43. PubMed ID: 23027589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.
    Holden PA; Nisbet RM; Lenihan HS; Miller RJ; Cherr GN; Schimel JP; Gardea-Torresdey JL
    Acc Chem Res; 2013 Mar; 46(3):813-22. PubMed ID: 23039211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico analysis of nanomaterials hazard and risk.
    Cohen Y; Rallo R; Liu R; Liu HH
    Acc Chem Res; 2013 Mar; 46(3):802-12. PubMed ID: 23138971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicological aspects for nanomaterial in humans.
    Dusinska M; Magdolenova Z; Fjellsbø LM
    Methods Mol Biol; 2013; 948():1-12. PubMed ID: 23070759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening.
    Nel A; Xia T; Meng H; Wang X; Lin S; Ji Z; Zhang H
    Acc Chem Res; 2013 Mar; 46(3):607-21. PubMed ID: 22676423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology.
    Oberdörster G
    J Intern Med; 2010 Jan; 267(1):89-105. PubMed ID: 20059646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The release of engineered nanomaterials to the environment.
    Gottschalk F; Nowack B
    J Environ Monit; 2011 May; 13(5):1145-55. PubMed ID: 21387066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creative use of analytical techniques and high-throughput technology to facilitate safety assessment of engineered nanomaterials.
    Liu Q; Wang X; Xia T
    Anal Bioanal Chem; 2018 Sep; 410(24):6097-6111. PubMed ID: 30066194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure science and the U.S. EPA National Center for Computational Toxicology.
    Cohen Hubal EA; Richard AM; Shah I; Gallagher J; Kavlock R; Blancato J; Edwards SW
    J Expo Sci Environ Epidemiol; 2010 May; 20(3):231-6. PubMed ID: 18985077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antibacterial effects of engineered nanomaterials: implications for wastewater treatment plants.
    Musee N; Thwala M; Nota N
    J Environ Monit; 2011 May; 13(5):1164-83. PubMed ID: 21505709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety of medicinal nanoproducts: new areas of toxicological research].
    Grudziński IP
    Rocz Panstw Zakl Hig; 2011; 62(3):239-46. PubMed ID: 22171512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transparent stakeholder engagement in practice: Lessons learned from applying comprehensive environmental assessment to research planning for nanomaterials.
    Powers C; Hendren C; Wang A; Davis JM
    Integr Environ Assess Manag; 2014 Oct; 10(4):498-510. PubMed ID: 24729532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of life cycle concepts for the development of safe nanoproducts.
    Som C; Berges M; Chaudhry Q; Dusinska M; Fernandes TF; Olsen SI; Nowack B
    Toxicology; 2010 Mar; 269(2-3):160-9. PubMed ID: 20025922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research strategy for evaluation methods of the manufactured nanomaterials in NIHS and importance of the chronic health effects studies].
    Hirose A; Nishimura T; Kanno J
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):15-25. PubMed ID: 20306702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomaterial health effects--part 1: background and current knowledge.
    Powell MC; Kanarek MS
    WMJ; 2006 Mar; 105(2):16-20. PubMed ID: 16628969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced tools for the safety assessment of nanomaterials.
    Fadeel B; Farcal L; Hardy B; Vázquez-Campos S; Hristozov D; Marcomini A; Lynch I; Valsami-Jones E; Alenius H; Savolainen K
    Nat Nanotechnol; 2018 Jul; 13(7):537-543. PubMed ID: 29980781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.